Michishige Terasaki Selected Research

Michishige Terasaki Research Topics

Disease

14	Atherosclerosis 03/2023 - 09/2010
9	Type 2 Diabetes Mellitus (MODY) 10/2023 - 01/2018
5	Fibrosis (Cirrhosis) 11/2023 - 01/2016
5	Atherosclerotic Plaque (Atheroma) 03/2023 - 09/2010
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 05/2020
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2023 - 07/2020
4	Hyperglycemia 07/2020 - 01/2015
3	Cardiomegaly (Heart Hypertrophy) 05/2022 - 08/2016
3	Hyperplasia 10/2019 - 10/2017
3	Body Weight (Weight, Body) 01/2015 - 07/2012
2	Insulinoma 07/2023 - 11/2022
2	Insulin Resistance 09/2020 - 07/2020
2	Inflammation (Inflammations) 10/2017 - 01/2016
1	Sitosterolemia 01/2024
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2024
1	Hypertriglyceridemia 12/2023
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 07/2023
1	Diabetic Neuropathies (Diabetic Neuropathy) 03/2023
1	Obesity 01/2022
1	Hyperthyroidism 03/2021
1	Graves Disease (Basedow Disease) 03/2021
1	Hypertension (High Blood Pressure) 07/2020
1	Dyslipidemias (Dyslipidemia) 07/2020
1	Vascular Remodeling 10/2019
1	Neointima 10/2019
1	Weight Gain 01/2019
1	Hypoglycemia (Reactive Hypoglycemia) 01/2019
1	Wounds and Injuries (Trauma) 10/2017
1	Glucose Intolerance 01/2017
1	Abdominal Aortic Aneurysm 01/2016

Drug/Important Bio-Agent (IBA)

13	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2012
9	ApolipoproteinsIBA 01/2024 - 09/2010
8	oxidized low density lipoproteinIBA 03/2023 - 09/2010
7	Apolipoproteins E (ApoE)IBA 03/2023 - 09/2010
5	Peptides (Polypeptides)IBA 03/2021 - 01/2012
4	LipidsIBA 01/2024 - 01/2013
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 07/2012
3	Advanced Glycation End ProductsIBA 03/2023 - 07/2020
3	IncretinsIBA 01/2022 - 01/2013
3	Dipeptidyl-Peptidase IV InhibitorsIBA 09/2021 - 01/2018
3	Sodium-Glucose Transport ProteinsIBA 10/2019 - 01/2015
3	Liraglutide FDA Link 01/2019 - 04/2014
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2023 - 01/2019
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2023 - 01/2015
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 07/2023 - 11/2022
2	AutoantibodiesIBA 07/2023 - 11/2022
2	C-PeptideIBA 07/2023 - 01/2021
2	Zinc Transporter 8IBA 07/2023 - 11/2022
2	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 05/2022 - 10/2019
2	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 07/2020 - 01/2018
2	Streptozocin (Streptozotocin)FDA Link 07/2020 - 01/2019
2	CholesterolIBA 07/2020 - 07/2012
2	Glucagon (Glukagon)FDA Link 05/2020 - 12/2019
2	gastric inhibitory polypeptide receptorIBA 01/2018 - 08/2016
2	Angiotensin IIIBA 08/2016 - 01/2016
2	Cholesterol Esters (Cholesteryl Esters)IBA 04/2014 - 09/2010
1	LDL Receptors (LDL Receptor)IBA 01/2024
1	Phytosterols (Plant Sterols)IBA 01/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023
1	LDL CholesterolIBA 12/2023
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 12/2023
1	APTIBA 11/2023
1	dulaglutideIBA 10/2023
1	semaglutideIBA 10/2023
1	AntibodiesIBA 07/2023
1	Receptor for Advanced Glycation End ProductsIBA 03/2023
1	LigandsIBA 03/2023
1	ImmunosorbentsIBA 11/2022
1	EnzymesIBA 11/2022
1	Messenger RNA (mRNA)IBA 05/2022
1	Proteins (Proteins, Gene)FDA Link 05/2022
1	Hormones (Hormone)IBA 01/2022
1	2- (2,5- difluorophenyl)- 5- (2- (methylsulfonyl)- 2,6- dihydropyrrolo(3,4- c)pyrazol- 5(4H)- yl)tetrahydro- 2H- pyran- 3- amineIBA 09/2021
1	pigment epithelium-derived factorIBA 03/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2021
1	IodineIBA 03/2021
1	Lithium Carbonate (Eskalith)FDA LinkGeneric 03/2021
1	Methimazole (Thiamazole)FDA LinkGeneric 03/2021
1	Insulin-Like PeptidesIBA 01/2021
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021
1	Acyl Coenzyme A (Acyl CoA)IBA 07/2020
1	Hemoglobins (Hemoglobin)IBA 03/2020
1	1,5-anhydroglucitolIBA 03/2020
1	AlbuminsIBA 03/2020
1	AdipokinesIBA 10/2019
1	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2019
1	dorsomorphinIBA 01/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	ipragliflozinIBA 01/2017
1	alogliptinIBA 01/2017
1	MK0626IBA 01/2016
1	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2016
1	Insulin (Novolin)FDA Link 01/2015
1	dapagliflozinIBA 01/2015
1	Sterol O-AcyltransferaseIBA 04/2014
1	Pro(3)- glucose-dependent insulinotropic polypeptideIBA 01/2013

Therapy/Procedure

3	Therapeutics 12/2023 - 01/2017
1	Injections 10/2023
1	Cardiopulmonary Resuscitation (CPR) 09/2020
1	Aftercare (After-Treatment) 01/2019